Optimizing hormone therapy for future reproductive performance in women with premature ovarian failure

Author： Gelbaya Tarek Vitthala Srisailesh Nardo Luciano Seif Morad

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.27, Iss.1, 2011-01, pp. : 1-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Breast density in women with premature ovarian failure using hormone therapy

By Benetti-Pinto Cristina Laguna Soares Patricia Magda Magna Luis Alberto Petta Carlos Alberto Santos Cesar Cabello Dos

Gynecological Endocrinology, Vol. 24, Iss. 1, 2008-01 ,pp. : 40-43

Informa Healthcare

Access to resources Recommend Favorite

Ovarian benign clear cell adenofibroma in a patient with premature ovarian failure after 8-year hormone replacement therapy

By Chen Rong Zhou Huimei Zhang Yiwen

Gynecological Endocrinology, Vol. 29, Iss. 3, 2013-03 ,pp. : 216-218

Informa Healthcare

Access to resources Recommend Favorite

Serum anti-Müllerian hormone expression in women with premature ovarian failure

By Méduri G. Massin N. Bachelot A. Fiori O. Kuttenn F. Misrahi M. Touraine P.

Human Reproduction, Vol. 22, Iss. 1, 2007-01 ,pp. : 117-123

Oxford University Press

Access to resources Recommend Favorite

Genetics. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women

By Murray Anna Webb James MacSwiney Felicity Shipley Emma L. Morton Newton E.

Human Reproduction, Vol. 14, Iss. 5, 1999-05 ,pp. : 1217-1218

Oxford University Press

Access to resources Recommend Favorite

Chromosomal abnormalities in women with premature ovarian failure

By Artini Paolo Giovanni Ruggiero Maria Papini Francesca Valentino Valeria Uccelli Alessia Cela Vito Genazzani Andrea Riccardo

Gynecological Endocrinology, Vol. 26, Iss. 10, 2010-10 ,pp. : 717-724

Informa Healthcare

Access to resources Recommend Favorite